FDA Drug Recalls

Recalls / Class II

Class IID-0701-2022

Product

Diflorasone Diacetate Ointment USP, 0.05%, Net Wt 60 g tubes, Rx only, Manufactured by: Teligent Pharm, Inc., Buena, New Jersey 08310, NDC 52565-063-60.

Affected lot / code info
Batch: 15876, Exp 8/31/2022; 16205, Exp. 11/30/2022

Why it was recalled

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Recalling firm

Firm
Teligent Pharma, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
105 Lincoln Avenue, N/A, Buena, New Jersey 08310

Distribution

Quantity
4532 tubes
Distribution pattern
Nationwide in the USA and Puerto Rico

Timeline

Recall initiated
2022-03-15
FDA classified
2022-03-21
Posted by FDA
2022-03-30
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0701-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls